|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Finerenone>> Market Analysis Reports |
Market Analysis Reports of Finerenone |
|
Global Finerenone API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031 ... with a CAGR of %during review period. Finerenone is a non-steroidal mineralocorticoid receptor antagonist ... , includes a total of 15 chapters: Chapter 1, to describe Finerenone API product scope, market overview ... Global Finerenone API Production, Demand and Key Producers, 2022-2028 ... well as details the characteristics of Finerenone API that contribute to its ... production locations, products portfolio, Finerenone API revenue, sales, ... , Segmentation by Purity ?98% ?95% Global Finerenone API Market, Segmentation by Application Treatment ... Global Nonsteroidal MRAs Market Growth 2024-2030 ... the introduction of nonsteroidal MRAs like finerenone, there has been a notable shift ... regions and countries. Segmentation by Type: Finerenone Esaxerenone Others Segmentation by Application: Heart ... Chronic Kidney Disease (Chronic Renal Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Chronic Kidney Disease (Chronic Renal Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease ( ... Heart failure - Pipeline Insight, 2021 ... . Heart failure Emerging Drugs Finerenone: Bayer HealthCare Pharmaceuticals Finerenone (BAY 94-8862) is an investigational ... Biopharmaceutical, Inc. Bial Key Products Finerenone IONIS-AGT-LRx HS 001 AZD ... Acute Renal Failure (Acute Kidney Injury) - Pipeline Review, 2019 ... Teprasiran Tolvaptan ANG 3777 Ularitide Finerenone DM 199 Drug Profile Overview: The ... Latestage chronic kidney disease (CKD) - Pipeline Review, 2019 ... KBP-5074 Ziltivekimab DM199 CTAP101 Finerenone DDO-3055 RBT-1 BI 764198 Bemethyl ... Diabetic Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Diabetic Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Drugs In Development, 2022 ... End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 ... with LASCO Pharmaceutical Division, launched finerenone, marketed as Firialta, to treat chronic kidney ... released pharmacodynamic results for Kerendia (finerenone), the first non-steroidal, effective ... Chronic Kidney Disease - Pipeline Review, H1 2017 Chronic Kidney Disease - Pipeline Review, H1 2017 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease - Pipeline Review, H1 2017, provides an overview of the Chronic Kidney Disease (Genito ... Heart failure with preserved ejection fraction (HFpEF) ... CardiolRx™100 Ranolazine hydrochloride Empagliflozin Finerenone TYA 11631 Global Kidney Fibrosis Treatment Market Size study & Forecast, by Therapeutics (Angiotensin II receptor blockers (ARBs), Angiotensin Converting Enzyme (ACE) inhibitors, Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors), by End User (hospital, Clinics, Home Treatment) and Regional Analysis, 2022-2029 ... , Bayer launched a new drug named finerenone for treatment of chronic kidney disease ... Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Drugs In Development, 2022 ... Global Aldosteronism Treatments Market Research Report 2025(Status and Outlook) ... therapies, as well as newer agents like finerenone, alongside surgical options (e.g., adrenalectomy for ... Chronic Heart Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major chronic heart failure markets reached a value of US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.5 Billion by 2034, exhibiting a growth rate (CAGR) of 9.78% during 2024-2034. The chronic heart failure ... |